Category Archives: ALERTS & INFORMATION

“BIOWIZARD”- RESEARCH MADE SIMPLE

BioWizard is a free, web-based community for life scientists and physicians, aimed at making the world’s biomedical research information universally accessible and useful.

As the first online portal to focus on both the dissemination of information and collaboration within the scientific community, BioWizard’s content is driven by its users helping them to streamline their research.

offers a host of features including its community driven Featured Articles section, PubMed search capability, up-to-the-minute field-specific news, table of contents from all major scientific and medical journals, a comprehensive products search, and online blogs that assist researchers in searching, sharing and discussing a myriad of interesting scientific information.

“KINARM” A VIRTUAL REALITY ARM

A virtual-reality technology invented in Canada could improve how health workers assess people suffering from brain injuries and brain diseases.

The KINARM combines a chair with robotic arms and a virtual-reality system that allows researchers to guide patients through tasks, such as hitting balls with virtual paddles.

Once the tests are done, the system gives a detailed report on how the patient differed from normal.

The system has several advantages over traditional testing methods, such as touching one’s finger or nose, said Prof. Stephen Scott of the Centre for Neuroscience Studies at Queen’s University in Kingston, Ont.

“No. 1 is that it is objective,” Scott said Monday from San Diego, where he is the presenting the research at the Society for Neuroscience Conference.

Currently, clinicians often assess patients with brain injuries and disease using crude, subjective scoring systems that range from zero to two, based on whether the patient can touch a nose or another object.

But those systems offer few choices, which makes to difficult to identify problems and show improvements after therapy, Scott said.

NEW BIOMEDICAL INITIATIVES GETTING FUNDING AROUND THE WORLD……..

Artificial heart maker gets $7.5 million grant

SynCardia Systems, 1992 E. Silverlake Road, manufacturer of the world’s only FDA-approved total artificial heart, has received a five-year, $7.5 million grant from the National Institutes of Health.

The grant was awarded to three of its researchers to optimize the design of cardiovascular devices.

The principal investigator on the project is Danny Bluestein, professor of Biomedical Engineering at Stony Brook University in New York. His collaborators are Shmuel Einav, also of Stony Brook College, and Dr. Marvin Slepian, professor of cardiology and biomedical engineering medicine at the University of Arizona,

Local company gains biomedical funding

Medical technology company Glenveigh Medical in Chattanooga is getting nearly half a million dollars in federal grants to pay for research that officials expect will boost America‘s role in biomedical research.

The federal “therapeutic discovery” grants and tax credits, awarded under national health care reform legislation and announced this month, provide more than $6.7 million to Tennessee recipients whose projects show “significant potential to produce new and cost-saving therapies, support good jobs and increase U.S. competitiveness,” according to the U.S. Department of Health and Human Services.

The only Chattanooga-based company awarded the grant this year was Glenveigh, which specializes in maternal-fetal medicine products. The company moved from Research Triangle Park in Raleigh-Durham, N.C., to Chattanooga in 2007.

About $81,000 in grants will help Glenveigh create a device for measuring cervical dilation during labor, and an additional $156,000 will help the company develop treatment for pre-eclampsia, a dangerous condition for pregnant women.

The company also received $244,479 for a device that can slow blood loss in women hemorrhaging after giving birth, said the company’s founders.

The “Ebb” device, developed by Salt Lake City-based maternal-fetal medicine specialists and licensed by Glenveigh, can reduce post-partum blood loss and prevent a hysterectomy or even death, said Richard Proctor, president and CEO of Glenveigh.

“This device is going to save lives,” he said.

read more………..

Federal Grants Advance Local Biomedical Research

NOW NEW ADVERTISEMENTS WILL DIRECTLY WHISPER INTO BRAIN…….

NEUROMARKETING

WHAT happens in our brains when we watch a compelling TV commercial?

For one thing, certain brain waves that correlate with heightened attention become more active, according to researchers who have used EEGs, or electroencephalographs, to study the brain’s electrical frequencies. Brain waves that signal less-focused attention, meanwhile, tend to subside.

In other words, this is your brain on ads.

Or so say neuromarketers, a nascent group of researchers who use techniques from neuroscience to analyze people’s responses to products and promotions.

Neuromarketing’s raison d’être derives from the fact that the brain expends only 2 percent of its energy on conscious activity, with the rest devoted largely to unconscious processing. Thus, neuromarketers believe, traditional market research methods — like consumer surveys and focus groups — are inherently inaccurate because the participants can never articulate the unconscious impressions that whet their appetites for certain products.

If pitches are to succeed, they need to reach the subconscious level of the brain, the place where consumers develop initial interest in products, inclinations to buy them and brand loyalty, says A. K. Pradeep, the founder and chief executive of NeuroFocus, a neuromarketing firm based in Berkeley, Calif.

A handful of neuromarketing firms, like EmSense, Sands Research, MindLab International and NeuroSense, now specialize in the latest mind-mining techniques — EEGs, M.R.I.’s, eye-tracking — or in older biometric methods that track skin, muscle or facial responses to products or ads.

Companies like Google, CBS, Disney, Frito-Lay and A & E Television, as well as some political campaigns, have used neuromarketing to test consumer impressions. And, in 2008, Nielsen invested in NeuroFocus, the largest of these firms, adding credibility to the field.

FIRST EXCLUSIVE ONLINE BIOMEDICAL JOB PORTAL FOR INDIA ( BMEJOBS.CO.IN) WITH SUPPORT OF BIOMEDIKAL.IN LAUNCHED……

ABOUT BMEJOBS.CO.IN

BMEjobs.co.in is India’s first ever job portal that showcases job from biomedical field. All the jobs will be related to biomedical and related branches. We offer you direct jobs from the company itself. We have our terms that no jobs are free. All jobs will be paid jobs(Except internships,which may lead to the job depending on the performance of the candidate)

INJECT STEM CELLS & DEFY AGING

Chicago: Injecting stem cells into injured mice made their muscles grow back twice as big in a matter of days, creating mighty mice with bulky muscles that stayed big and strong for the rest of their lives, U.S. researchers said on Wednesday.
If the same applies to humans, the findings could lead to new treatments for diseases that cause muscles to deteriorate, such as muscular dystrophy. It may even help people resist the gradual erosion of muscle strength that comes with age, Bradley Olwin, of the University of Colorado at Boulder, and colleagues reported in the journal Science Translational Medicine.
“This was a very exciting and unexpected result,” Olwin, who worked on the study, said.“We found that the transplanted stem cells are permanently altered and reduce the aging of the transplanted muscle, maintaining strength and mass,” he added.
Olwin’s team experimented on young mice with leg injuries, injecting them with muscle stem cells taken from young donor mice. Stem cells are unique in that they can constantly renew themselves, and form the basis of other specialized cells. These cells not only repaired the injury, but they caused the treated muscle to increase in size by 170%.
Olwin’s team had thought the changes would be temporary, but they lasted through the lifetime of the mice, which was about two years.
Olwin and colleagues said when they injected the cells into a healthy leg, they did not get the same effect, suggesting there is something important about injecting the cells into an injured muscle that triggers growth. REUTERS